Authors: Kovarik, JM Sabia, HD Figueiredo, J Zimmermann, H Reynolds, C Dilzer, SC Lasseter, K Rordorf, C

Citation: Jm. Kovarik et al., Influence of hepatic impairment on everolimus pharmacokinetics: Implications for dose adjustment, CLIN PHARM, 70(5), 2001, pp. 425-430

Authors: Kovarik, JM Hsu, CH McMahon, L Berthier, S Rordorf, C

Citation: Jm. Kovarik et al., Population pharmacokinetics of everolimus in de novo renal transplant patients: Impact of ethnicity and comedications, CLIN PHARM, 70(3), 2001, pp. 247-254

Authors: Kovarik, JM Kahan, BD Kaplan, B Lorber, M Winkler, M Rouilly, M Gerbeau, C Cambon, N Boger, R Rordorf, C

Citation: Jm. Kovarik et al., Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-responserelationships, and influence on cyclosporine, CLIN PHARM, 69(1), 2001, pp. 48-56